Funding for this research was provided by:
National Heart, Lung, and Blood Institute (HL107882, HL118954, T32 HL094284)
Boehringer Ingelheim (N/A)
Received: 29 January 2020
Accepted: 6 July 2020
First Online: 29 July 2020
Ethics approval and consent to participate
: Weill Cornell Medicine (WCM) Institutional Review Board approved the protocols. Research subjects were evaluated and consented at the Weill Cornell Medical College Clinical Translational and Science Center and the Department of Genetic Medicine Clinical Research Facility.
: Not applicable.
: The authors declare that they have no competing interests.